Patients' access to drugs with rebates in Switzerland - Empirical analysis and policy implications for drug pricing in Europe

• 主要な著者: David L Carl, BA (著者), Kerstin N Vokinger, MD, JD, PhD, LLM (著者)
• フォーマット: 図書
• 出版事項: Elsevier, 2021-04-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Background: Many European countries introduced (confidential) rebates in the past years. Authorities and manufacturers argue that this strategy allows reduction of spending on high-cost drugs, and quick access of innovative drugs. We evaluated these arguments using Switzerland as an example, one of...